259 related articles for article (PubMed ID: 8717154)
21. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
[TBL] [Abstract][Full Text] [Related]
22. The activity of 5-HT1D receptor ligands at cloned human 5-HT1D alpha and 5-HT1D beta receptors.
Walsh DM; Beattie DT; Connor HE
Eur J Pharmacol; 1995 Dec; 287(1):79-84. PubMed ID: 8666030
[TBL] [Abstract][Full Text] [Related]
23. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
24. Sequence and functional analysis of cloned guinea pig and rat serotonin 5-HT1D receptors: common pharmacological features within the 5-HT1D receptor subfamily.
Wurch T; Palmier C; Colpaert FC; Pauwels PJ
J Neurochem; 1997 Jan; 68(1):410-8. PubMed ID: 8978753
[TBL] [Abstract][Full Text] [Related]
25. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA
Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718
[TBL] [Abstract][Full Text] [Related]
26. Stereoselectivity of 8-OH-DPAT enantiomers at cloned human 5-HT1D receptor sites.
Pauwels PJ; Colpaert FC
Eur J Pharmacol; 1996 Apr; 300(1-2):137-9. PubMed ID: 8741179
[TBL] [Abstract][Full Text] [Related]
27. 5-Hydroxytryptamine 5-HT1D receptors mediating inhibition of cyclic AMP accumulation in Madin-Darby canine kidney (MDCK) cells.
Schoeffter P; Bobirnac I
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):256-62. PubMed ID: 8584040
[TBL] [Abstract][Full Text] [Related]
28. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological characterisation of [35S]-GTPgammaS binding to Chinese hamster ovary cell membranes stably expressing cloned human 5-HT1D receptor subtypes.
Thomas DR; Faruq SA; Balcarek JM; Brown AM
J Recept Signal Transduct Res; 1995; 15(1-4):199-211. PubMed ID: 8903941
[TBL] [Abstract][Full Text] [Related]
30. Molecular cloning and pharmacological characterization of guinea pig 5-HT1B and 5-HT1D receptors.
Zgombick JM; Bard JA; Kucharewicz SA; Urquhart DA; Weinshank RL; Branchek TA
Neuropharmacology; 1997; 36(4-5):513-24. PubMed ID: 9225276
[TBL] [Abstract][Full Text] [Related]
31. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
32. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
33. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
34. Species differences in presynaptic serotonin autoreceptors: mainly 5-HT1B but possibly in addition 5-HT1D in the rat, 5-HT1D in the rabbit and guinea-pig brain cortex.
Limberger N; Deicher R; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):353-64. PubMed ID: 1852219
[TBL] [Abstract][Full Text] [Related]
35. The 5-HT1-like receptor mediating the increase in canine external carotid blood flow: close resemblance to the 5-HT1D subtype.
Villalón CM; Terrón JA
Br J Pharmacol; 1994 Sep; 113(1):13-20. PubMed ID: 7812603
[TBL] [Abstract][Full Text] [Related]
36. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
Bouhelal R; Smounya L; Bockaert J
Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
[TBL] [Abstract][Full Text] [Related]
37. Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery.
MacLean MR; Clayton RA; Templeton AG; Morecroft I
Br J Pharmacol; 1996 Sep; 119(2):277-82. PubMed ID: 8886409
[TBL] [Abstract][Full Text] [Related]
38. 5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies.
Piñeyro G; de Montigny C; Blier P
Neuropsychopharmacology; 1995 Nov; 13(3):249-60. PubMed ID: 8602897
[TBL] [Abstract][Full Text] [Related]
39. Chimeric receptor analysis of the ketanserin binding site in the human 5-Hydroxytryptamine1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding.
Wurch T; Colpaert FC; Pauwels PJ
Mol Pharmacol; 1998 Dec; 54(6):1088-96. PubMed ID: 9855638
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.
Giles H; Lansdell SJ; Bolofo ML; Wilson HL; Martin GR
Br J Pharmacol; 1996 Mar; 117(6):1119-26. PubMed ID: 8882605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]